###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Leukocyte Antigen Class II Association with Spontaneous Recovery from Hepatitis B Virus Infection in Koreans: Analysis at the Haplotype Level
###end article-title 0
###begin p 1
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 804 805 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 901 902 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 902 903 902 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 101 118 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 120 123 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 235 238 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1286 1289 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
It has been speculated that human leukocyte antigen (HLA) alleles are associated with the outcome of hepatitis B virus (HBV) infection although the data obtained from various populations have shown some inconsistencies. A total of 464 HBV-infected Korean individuals (80 spontaneously recovered [SR] and 384 chronically infected [CI]) were selected to investigate the association of HLA class II alleles with the viral clearance and persistence. Our results showed that: 1) multiple HLA class II alleles and haplotypes were associated with viral clearance (DRB1*1302, DRB1*1502, DQB1*0302, DQB1*0609, and related-haplotypes) and persistence (DRB1*0701, DQB1*0301, and related-haplotypes); 2) DRB1*1302 and DQB1* 0609 were more strongly associated with viral clearance. And the association of DQB1*0609 (pc=0.0084; OR, 7.24) with vial clearance was much stronger than previously recognized, DRB1*1302 (pc=0.0038; OR, 4.34); and 3) linkage to a specific DPB1 allele in a haplotype strengthened the association with viral clearance, although DPB1 itself was not associated with the outcome. These results indicate the existence of multiple factors controlling viral clearance in the HLA class II gene region. Further extended investigation on the genetic factors related to the outcome of HBV infection will provide valuable insights into the understanding of the mechanisms involved.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 15 38 <span type="species:ncbi:10407">human hepatitis B virus</span>
###xml 40 43 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 181 187 <span type="species:ncbi:9606">people</span>
###xml 216 219 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 296 304 <span type="species:ncbi:9606">children</span>
###xml 474 477 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Infection with human hepatitis B virus (HBV) can lead to high morbidity and mortality due to the development of end-stage liver diseases. It is estimated that more than 350 million people worldwide are infected with HBV (1). Among infected individuals, about 5-10% of adults and more than 90% of children become persistently infected by the virus and develop liver diseases. The clinical outcome of the infection is variable and may result in spontaneous recovery, inactive HBV surface antigen (HBsAg) carrier state, chronic hepatitis, liver cirrhosis, or hepatocellular carcinoma (2, 3). The precise mechanisms leading to these various outcomes are not clearly defined yet but it has been perceived that host immune responsiveness is the critical factor.
###end p 3
###begin p 4
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 948 949 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 87 90 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 121 124 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 344 349 <span type="species:ncbi:9606">human</span>
###xml 443 446 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 588 591 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
It has been demonstrated that vigorous CD4+ and CD8+ T lymphocyte responses to various HBV antigens were associated with HBV self-elimination, while insufficient CD4+ T cell help and defective CD8+ T cell repertoire at the early stages of infection were connected to viral persistence (4, 5). Due to the specific antigen presenting function of human leukocyte antigens (HLA) in immune responsiveness, the contribution of HLA to the outcome of HBV infection has been studied extensively in different populations. However, data have shown some inconsistencies with regard to HLA effects on HBV clearance or persistence in different ethnic and racial groups. Extensive HLA polymorphism contributes to the selection of antigenic peptides for presentation to T lymphocytes resulting in different immune responses to infection amongst individuals. Furthermore, HLA molecules differing only at 1-2 amino acids showed different peptide binding preference (6). This implies that HLA analysis for disease association studies requires high resolution typing to better understand the mechanisms involved.
###end p 4
###begin p 5
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 29 32 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 269 272 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
###xml 613 616 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Korea is an endemic area for HBV infection and about 5% of the population has been shown to be chronically infected (7). Two studies regarding HLA association in Koreans have been reported and consistently demonstrated that DR13 was associated with self-elimination of HBV (8, 9). However, these studies to clarify the HLA association in the population were limited in several respects. They examined only HLA-A, -B, and -DR at low resolution and used patients with organ transplants as their study subjects. Therefore, the purpose of this study was to further investigate the HLA association with the outcome of HBV infection using high resolution typing of HLA class II loci (HLA-DRB1, -DQB1, and -DPB1). The impact of HLA diversity was evaluated on viral clearance and persistence.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Study subjects
###end title 7
###begin p 8
###xml 47 50 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 94 97 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 347 350 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 590 593 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1304 1307 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1464 1472 <span type="species:ncbi:9606">patients</span>
###xml 1503 1511 <span type="species:ncbi:9606">Patients</span>
###xml 1578 1586 <span type="species:ncbi:9606">patients</span>
###xml 1670 1681 <span type="species:ncbi:11103">hepatitis C</span>
###xml 1842 1847 <span type="species:ncbi:9606">Human</span>
A total of 464 Koreans who had been exposed to HBV as detected by the presence of antibody to HBV core antigen (anti-HBc) IgG, were enrolled from the outpatient clinics of the Gastroenterology Department of Ajou University Hospital (Suwon, Korea) between March and December 2002. Study subjects were divided into two groups based on the status of HBV serologic markers exhibited for more than 6 months. The spontaneously recovered (SR) group included 80 individuals (60 males and 20 females, aged 19-70 yr, mean+/-SD, 47.9+/-10.3) who were HBsAg negative, anti-HBc positive and antibody to HBV surface antigen (anti-HBs) positive, and had no evidence of liver function abnormalities and of previous chronic liver disease based on their medical history. The chronically infected (CI) group included 384 individuals (283 males and 101 females, aged 16-77 yr, mean+/-SD, 41.0+/-10.3) who were HBsAg and anti-HBc positive, and anti-HBs negative. They were regularly followed with blood tests for serum alanine aminotransferase (ALT)/aspartate aminotransferase (AST), hepatitis B e antigen (HBeAg)/antibody to hepatitis B e antigen (anti-HBe) and alpha fetoprotein (AFP), and with radiographic tests of the liver (computed tomography or ultrasonography) at an interval of every 6 months for more than a year. HBV-DNA was detected by Digene Hybrid Capture II Assay (Digene Diagnostics, Beltsville, MD, U.S.A.); the detection limit of the test was 0.5 pg/mL. None of the patients had hepatocellular carcinoma. Patients who were positive for anti-HBs and negative for anti-HBc IgG, and patients with other types of chronic liver disease such as alcoholic liver disease, chronic hepatitis C, steatohepatitis, and Wilson's disease, were excluded from this study. Informed consents were obtained from each subject, and the Institutional Review Board of Human Research of Ajou University Hospital approved the study protocol.
###end p 8
###begin title 9
HLA allelic typing
###end title 9
###begin p 10
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Genomic DNA was extracted from peripheral blood mononuclear cells of the study subjects using the method of Miller and colleagues (10). Allele-level genotypes of the HLA-DRB1, -DQB1, and -DPB1 genes from each study sample were obtained by direct DNA sequence analysis based on the procedures described previously (11-13). Briefly, the polymorphic exon 2 of the gene was amplified using group-specific (HLA-DRB1) or locus-specific (HLA-DQB1, and -DPB1) primer sets. Automated cycle sequencing using dye terminator chemistry (v3.1, Applied Biosystems, Foster City, CA, U.S.A.) was performed on the amplified gene product and the amplicon was analyzed on an ABI3100 Genetic Analyzer (Applied Biosystems). Data analysis was performed with Sequence Navigator and MatchTool software (PE-Applied Biosystems Inc., U.S.A.). Homozygosity was assumed when no other HLA-DRB1, -DQB1, and -DPB1 allele was detected upon direct DNA sequence analysis.
###end p 10
###begin title 11
Statistical analysis
###end title 11
###begin p 12
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 787 788 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 991 992 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1098 1099 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1115 1116 1115 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1198 1199 1198 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 854 857 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Statistical analyses were done using SAS (version 8.01, SAS institute, Cary, NC). Haplotype reconstruction was implemented by PHASE (14). Hardy-Weinberg equilibrium for all loci and linkage disequilibrium for all pairs of loci were tested using Arlequin (version 2.0, Genetics and Biometry Laboratory, University of Geneva, Switzerland). Phenotype frequencies of HLA-DRB1, -DQB1, and -DPB1 alleles as well as haplotype frequencies of DRB1-DQB1, DQB1-DPB1, and DRB1-DQB1-DPB1 in two study groups were compared. Alleles (<3%) and haplotypes (<2%) with low frequencies were not analyzed due to inadequate statistical power. Some general characteristics were compared between the two study groups using t-test and chi-square test. Odd ratios (ORs) with 95% confidence intervals (95% CI) and p values for alleles and haplotypes associated with the outcome of HBV infection were calculated by logistic regression analysis adjusting for age and sex. When one element in the 2x2 table was zero, the p value was calculated by a chi-square test in haplotype analysis. Statistical significance was assumed at p<0.05. When the p value was less than 0.05, a Bonferroni correction was applied by multiplying the p value by the number of comparisons made.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin title 14
Characteristics of study groups
###end title 14
###begin p 15
###xml 168 169 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 309 310 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 6 9 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Among HBV-exposed subjects including SR group (n=80) and CI group (n=384), the SR group (47.9+/-10.3 yr old) was somewhat older than the CI group (41.0+/-10.3 yr old) (p<0.0001). However, regarding gender, there was no significant difference between the SR group (% male=75.0) and the CI group (% male=73.7) (p>0.1).
###end p 15
###begin title 16
###xml 24 27 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Alleles associated with HBV clearance or persistence
###end title 16
###begin p 17
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Using direct DNA sequencing analysis, class II allele genotypes at the four-digit level were obtained from the study subjects. A total of 31 HLA-DRB1, 16 HLA-DQB1, and 23 HLA-DPB1 alleles were identified. Distribution of the alleles for all loci were consistent with Hardy-Weinberg equilibrium in the SR and CI groups, respectively (p>0.05).
###end p 17
###begin p 18
###xml 84 91 84 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 364 365 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 378 379 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
Phenotype frequencies of HLA class II alleles in the two study groups are listed in Table 1. The frequencies of DRB1* 1302 (17.50% vs. 4.95%, p=0.0002, OR, 4.34) and DQB1*0609 (10.00% vs. 1.56%, p=0.0006, OR, 7.24) were significantly higher in the SR group compared to the CI group. Their statistical significance was maintained after correction of the p values (pc=0.0038 and pc=0.0084, respectively). The frequencies of DRB1*1502 and DQB1*0302 were higher in the SR group, while the frequencies of DRB1*0701 and DQB1*0301 were higher in the CI group. However, p values were not statistically significant after the correction (Table 1).
###end p 18
###begin title 19
###xml 55 58 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Comparison of the impact of DRB1*1302 and DQB1*0609 on HBV clearance
###end title 19
###begin p 20
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 895 902 895 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1044 1045 1044 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1116 1117 1116 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1125 1126 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1126 1127 1126 1127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 94 97 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 469 472 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1383 1386 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
As described above, two alleles (DRB1*1302 and DQB1* 0609) were significantly associated with HBV clearance. Interestingly, all of the individuals carrying DQB1*0609 were DRB1*1302-positive in this study. This is due to the strong linkage disequilibrium between these two alleles in Koreans as previously described (15). Thus, the statistics for these two alleles might be distorted and an additional analysis was necessary to estimate the impact of the two alleles on HBV clearance. Fortunately, DRB1*1302 also showed strong linkage disequilibrium with DQB1*0604 in the study population (15). About 42% of DRB1*1302+ Korean individuals carry DQB1*0609 and the remainder (58%) carry DQB1* 0604. Thus, the significance of those two clearance alleles were indirectly evaluated by comparing haplotype frequencies of DRB1*1302-DQB1*0609 and DRB1*1302-DQB1* 0604 in the two study groups. As shown in Table 2, the frequency of DRB1*1302-DQB1*0609 was much higher in the SR group than in the CI group with a statistical significance (5.63% vs. 0.78%, p=0.0002, OR, 7.57), and its significance remained after correcting the p value (pc=0.0040). Although it was still elevated in the SR group (3.75% vs. 1.82%), the frequency of the second haplotype, DRB1*1302-DQB1*0604, was not statistically different between the two groups. In conclusion, DQB1*0609 was the primary allele associated with HBV clearance. The observed association of clearance with DRB1*1302 might be due to the DRB1 allele itself and/or to the linked DQB1*0609.
###end p 20
###begin title 21
###xml 27 30 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Haplotypes associated with HBV clearance or persistence
###end title 21
###begin p 22
###xml 107 114 107 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 257 264 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 386 387 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 429 430 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 606 607 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 819 820 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 906 913 906 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
Two- and three-locus HLA class II haplotypes associated with viral clearance and persistence are listed in Table 3. All of the haplotypes, except two (DQB1*0303-DPB1*0201, DRB1*0901-DQB1*0303-DPB1*0201), carried at least one of the outcome-related alleles (Table 1). For example, three DRB1*1302- and DQB1*0609-related haplotypes (DRB1*1302-DQB1*0609 (pc=0.0040), DQB1*0609-DPB1*0201 (pc=0.0260), DRB1*1302-DQB1*0609-DPB1*0201 (pc=0.0190)) were strongly associated with viral clearance as DRB1*1302 and DQB1*0609 themselves were. The haplotypes maintained statistical significances after correction of the p values. Other haplotypes associated with viral clearance were DRB1*1502- and DQB1*0302-related haplotypes. Haplotypes associated with viral persistence were DQB1*0301- and DRB1*0701-related haplotypes. However, p values for those haplotypes were not statistically significant after the correction (Table 3).
###end p 22
###begin p 23
###xml 94 101 94 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 79 82 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Although none of the DPB1 allele appeared to be associated with the outcome of HBV infection (Table 1), there was an indirect association of DPB1 with viral clearance observed at the haplotype level (Table 3). On a haplotype (DQB1* 0303-DPB1*0201, p=0.0091, OR, 2.61) associated with viral clearance with a statistical significance, neither DQB1* 0303 (26.25% vs. 25.00%) nor DPB1*0201 (40.00% vs. 37.50%) alone was associated with viral clearance as shown in Table 1. However, a haplotype consisting of these two alleles appeared to be associated with viral clearance. Furthermore, the OR value of its 3-locus haplotype, DRB1*0901-DQB1* 0303-DPB1*0201 (OR, 2.74), was similar to that of DQB1* 0303-DPB1*0201 (OR, 2.61). We could observe a similar phenomenon in another example. DQB1*0609 (OR, 7.24) was strongly associated with viral clearance as described above. However, linking this allele to statistically insignificant DPB1*0201 again in a haplotype DQB1*0609-DPB1*0201 increased the OR value (OR, 9.93). In a three-locus haplotype, DRB1*1302-DQB1*0609-DPB1*0201, the OR value was even higher (OR, 14.92).
###end p 23
###begin title 24
DISCUSSION
###end title 24
###begin p 25
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 58 61 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 321 324 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 445 448 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 683 686 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 690 696 <span type="species:ncbi:9606">humans</span>
###xml 729 732 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 896 899 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 940 948 <span type="species:ncbi:9606">patients</span>
From the study of the HLA association with the outcome of HBV infection, we found that two HLA class II alleles are strongly associated with viral clearance. The first allele was DRB1*1302 and this result was concordant with two previous Korean studies that demonstrated that DR13 was associated with self-elimination of HBV (8, 9). In addition, DRB1*1302 has been consistently reported as a factor associated with protection against persistent HBV infection in two other racial groups, Africans (16) and Caucasians (17, 18). Identification of the same HLA allele and/or serologic type from various populations strongly suggests that there is at least one common element restricting HBV in humans. A beneficial effect of DR13 on HBV infection has also been confirmed by functional assay. Diepolder et al. demonstrated that DR13-positive individuals showed a more vigorous CD4+ T cell response to HBV core antigen (HBcAg) than DR13-negative patients (19). DR13-restricted CD4+ T cell epitopes of HBcAg were later discovered (20).
###end p 25
###begin p 26
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 983 984 983 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1016 1017 1016 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1390 1392 1390 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 188 191 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 442 445 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 725 733 <span type="species:ncbi:9606">patients</span>
###xml 754 757 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 957 965 <span type="species:ncbi:9606">children</span>
###xml 1375 1378 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1484 1492 <span type="species:ncbi:9606">patients</span>
The second allele associated with viral clearance was DQB1* 0609, which is in strong linkage disequilibrium with DRB1* 1302 in the study population. The impact of the DQB1* 0609 allele on HBV clearance was indirectly analyzed by comparing frequencies of the two DRB1*1302-positive haplotypes, DRB1*1302-DQB1*0609 and DRB1*1302-DQB1* 0604, between the two study groups. The result indicates that DQB1*0609 has a much stronger association with HBV clearance than DRB1*1302 and we believe that DQB1* 0609 is the primary class II allele associated with viral clearance. This hypothesis is supported by several previous studies. First, there has been a report that the phenotype frequency of DQw1 was significantly lower in Dutch patients with chronic active HBV infection (21) (DQB1*0609 is one of the alleles encoding the DQw1 molecule). In addition, a study in Gambians indicated that the frequency of DQB1* 06 linked to DRB1*1302 was significantly higher in children (11.9% vs. 6.5%, p=0.06) and adults (9.2% vs. 0%, p=0.05) who cleared the virus than in individuals who carried the virus persistently (16). Later, DQB1*0609 was found to be relatively frequent in Gambians (DQB1*0609=4.4%; DQB1*0604=0.7%) (22). Lastly, it has been demonstrated that DR13-positive individuals exhibited a more vigorous CD4+ T cell response to HBcAg than DR13-negative individuals during acute HBV infection (19). However, less than 10% of the HBc-specific CD4+ T cell clones derived from DR13-positive patients were DR13-restricted. This result left open the possibility that the majority of the CD4+ T cell clones (>90%) might be restricted to other HLA class II molecules including DQw1 encoded by a DQB1*06 allele in DR13-positive individuals.
###end p 26
###begin p 27
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 99 102 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 234 237 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 574 577 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Therefore, for the first time, we have shown that DQB1* 0609 is the primary allele associated with HBV clearance and its association is much stronger than previously found for DRB1*1302. In most of the previous association studies on HBV clearance, DQB1 high resolution typing was not performed. Only three studies so far analyzed DQB1 at allele resolution; however, the frequencies of DQB1*0609 might have been too low in the study populations to catch its statistical significance (18, 23, 24). That could be the reason why DQB1*0609 has not been identified thus far with HBV clearance. Our hypothesis needs to be confirmed by further studies in populations expressing a high frequency of this allele.
###end p 27
###begin p 28
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 537 538 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 538 539 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 620 621 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 75 78 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 520 523 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 822 825 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 992 999 <span type="species:ncbi:9606">patient</span>
###xml 1139 1142 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Several additional alleles were found to be associated with the outcome of HBV infection in this study, although the result did not reach statistical significance. The increased frequency of DRB1*1502 in the SR group was consistent with previous studies in Qartar (25) and China (26). Likewise, the higher frequencies of DRB1*0701 (9, 25) and DQB1*0301 (23, 24) in the CI group were consistent with previous reports. One of the previous studies analyzed a Korean population and found significant association of DR7 with HBV persistence (pc<0.001) (9). Another study in the same population found a high frequency of DR9 (p<0.001), instead of DR7, in the CI group (8). These discrepancies might stem from differences in the study subjects. In our study, the study samples were recruited from outpatient clinics based on the HBV serologic markers. Previous studies analyzed the compiled HLA typing data of individuals undergoing organ transplantation and their donors where HLA matching between patient and donor is beneficial. Thus, the HLA frequencies in those studies could have been biased. DQB1*0302, found in this study associated with HBV clearance, has not been identified previously.
###end p 28
###begin p 29
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 730 733 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1108 1111 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
During the analysis of HLA class II multi-locus haplotypes, we found several related haplotypes carrying outcome-related alleles. Interestingly, association with viral clearance is significantly intensified on DQB1-DPB1 haplotypes consisting of a DQB1 allele (either a statistically insignificant allele [e.g., DQB1*0303] or a clearance-associated allele [e.g., DQB1*0609]) and the statistically insignificant DPB1*0201, compared to OR values of the DQB1 allele alone. These results indicate that a DPB1 allele in combination with a DQB1 allele has either a cooperative (or synergistic) protective effect since DPB1*0201 (40.0% vs. 37.5%) alone has no effect. Alternatively, there might be another gene influencing the outcome of HBV infection located near the DPB1 gene. Several polymorphic genes, such as LMP, DM, and DO, whose gene products assist in antigen binding to the HLA molecules in a cell, are known to be located between DQB1 and DPB1 genes (27). Further extended investigation of these polymorphic genes might elucidate the cooperative (or synergistic) modification of immune responsiveness to HBV infection. Whether it is a cooperative (or synergistic) interaction or a closely linked gene, factor other than DR and DQ alleles might be involved in viral clearance.
###end p 29
###begin p 30
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 96 97 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 90 93 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 242 245 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The DRB1*1302-DQB1*0609-DPB1*0201 haplotype shows the strongest protective effect against HBV (pc=0.0190, OR, 14.92). Based on the results obtained from this study, it is most likely that the strong protective effect of the haplotype against HBV persistence might derive from three different factors: DRB1*1302, DQB1*0609, and another unknown factor linked to DPB1 as just described. Further investigations should be made to identify this.
###end p 30
###begin p 31
###xml 729 732 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
In summary, multiple HLA class II alleles and related haplotypes are associated with viral clearance and persistence in Koreans. In specific, DRB1*1302 and DQB1*0609 are strongly associated with viral clearance. However, unexpectedly, the association of DQB1*0609 is much stronger than that of DRB1*1302. In addition, the association with a statistically insignificant DPB1 allele in a haplotype strengthens the association with viral clearance, hinting that another unknown factor might be involved in viral clearance. These results may reflect the existence of multiple factors controlling viral clearance encoded in the HLA class II gene region. Further extended investigation on the genetic factors related to the outcome of HBV infection will provide valuable insights into the understanding of the mechanisms involved.
###end p 31
###begin p 32
###xml 46 124 46 124 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korea Health 21 R&amp;D Project, Ministry of Health and Welfare, Republic of Korea</funding-source>
###xml 126 133 126 133 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A010383</award-id>
This research was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A010383).
###end p 32
###begin article-title 33
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
Hepatitis B virus infection
###end article-title 33
###begin article-title 34
Natural history of hepatitis B and C virus infections
###end article-title 34
###begin article-title 35
Chronic hepatitis B
###end article-title 35
###begin article-title 36
Immunology of hepatitis B infection
###end article-title 36
###begin article-title 37
###xml 12 15 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 58 61 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 80 83 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 84 87 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection
###end article-title 37
###begin article-title 38
Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain
###end article-title 38
###begin article-title 39
Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea
###end article-title 39
###begin article-title 40
###xml 20 37 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between hepatitis B virus infection and HLA-DR type in Korea
###end article-title 40
###begin article-title 41
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 77 94 <span type="species:ncbi:10407">hepatitis B virus</span>
Human leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans
###end article-title 41
###begin article-title 42
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 42
###begin article-title 43
Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: Sequencing based typing of HLA-DRB genes
###end article-title 43
###begin article-title 44
Sequence-based typing for HLA-DQB1 strategy for ABI sequencing equipment
###end article-title 44
###begin article-title 45
Sequence-based typing for HLA-DPB1 strategy for ABI equipment
###end article-title 45
###begin article-title 46
A new statistical method for haplotype reconstruction from population data
###end article-title 46
###begin article-title 47
Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population
###end article-title 47
###begin article-title 48
###xml 60 77 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
###end article-title 48
###begin article-title 49
HLA-DRB1*1301 and *1302 protect against chronic hepatitis B
###end article-title 49
###begin article-title 50
###xml 72 89 <span type="species:ncbi:10407">hepatitis B virus</span>
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection
###end article-title 50
###begin article-title 51
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B
###end article-title 51
###begin article-title 52
Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B
###end article-title 52
###begin article-title 53
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 52 69 <span type="species:ncbi:10407">hepatitis B virus</span>
HLA antigens in patients with various courses after hepatitis B virus infection
###end article-title 53
###begin article-title 54
HLA-DPA1, -DPB1, DQA1, and -DQB1 allele frequencies in a population from Gambia
###end article-title 54
###begin article-title 55
###xml 25 42 <span type="species:ncbi:10407">hepatitis B virus</span>
Class II HLA alleles and hepatitis B virus persistence in African Americans
###end article-title 55
###begin article-title 56
Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B
###end article-title 56
###begin article-title 57
HLA and hepatitis B infection
###end article-title 57
###begin article-title 58
###xml 20 37 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China
###end article-title 58
###begin article-title 59
###xml 26 31 <span type="species:ncbi:9606">human</span>
Molecular genetics of the human major histocompatibility complex
###end article-title 59
###begin p 60
###xml 57 60 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Comparison of HLA class II phenotype frequencies between HBV spontaneously recovered (SR) and chronically infected (CI) groups
###end p 60
###begin p 61
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
PF, phenotype frequency of HLA allele is presented in percentage; pc value, p value corrected by multiplying the number of alleles tested (19 for DRB1, 14 for DQB1); OR, odds ratio (SR group vs. CI group); CI, confidence interval; NS, statistically not significant after correction.
###end p 61
###begin p 62
Alleles with a phenotype frequency >3% are listed.
###end p 62
###begin p 63
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
Only significant pc values (<0.05) are presented.
###end p 63
###begin p 64
Comparison of DRB1*1302-related haplotype frequencies between the SR and CI groups
###end p 64
###begin p 65
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
SR, spontaneously recovered; CI, chronically infected; HF, haplotype frequency is presented in percentage; pc value, p value corrected by multiplying the number of haplotypes tested (20 for DRB1-DQB1); OR, odds ratio (SR group vs. CI group); CI, confidence interval.
###end p 65
###begin p 66
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
Only significant pc values (<0.05) are presented.
###end p 66
###begin p 67
Two- and three-locus haplotypes associated with viral clearance and persistence
###end p 67
###begin p 68
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 373 374 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 374 375 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
SR, spontaneously recovered; CI, chronically infected; HF, frequency of allele or haplotype is presented in percentage; pc value, p value corrected by multiplying the number of haplotypes tested (20 for DRB1-DQB1; 20 for DQB1-DPB1; 19 for DRB1-DQB1-DPB1); OR, odds ratio (SR group vs. CI group); CI, confidence interval; NS, statistically not significant after correction (pc->0.05); NA, not applicable.
###end p 68
###begin p 69
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 3 4 3 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*, p value was calculated by chi-square test.
###end p 69

